In addition, in a rat model of transient focal cerebral ischemia and middle cerebral artery occlusion (MCAO), ECFCs primed with erythropoietin (EPO) were shown to have enhanced efficacy for reversing stroke injury (22, 23). Here, EPO is linked to Stroke.